×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Showing results for
Fennec
Pharma
Search instead for
Fennec Pharms
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in ...
PR Newswire
Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the...
2 months ago
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript
Yahoo Finance
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript March 21, 2024 Fennec Pharmaceuticals Inc. isn't one of the 30...
2 months ago
Norgine secures Pedmarqsi licence from Fennec in deal worth up to $272m
Pharmaceutical Technology
Fennec's Pedmarqsi/Pedmark is the only approved therapy to treat cisplatin-induced hearing loss in paediatric cancer patients.
2 months ago
Fennec Pharmaceuticals: Great Sales Progress – Not Yet Reflected In Stock (NASDAQ:FENC)
Seeking Alpha
Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Price · Increased the 2030 penetration rate to 28% in the core...
2 months ago
Craig Hallum Trims Fennec Pharmaceuticals (NASDAQ:FENC) Target Price to $17.00
Defense World
Read Craig Hallum Trims Fennec Pharmaceuticals (NASDAQ:FENC) Target Price to $17.00 at Defense World.
5 days ago
Investors bid Fennec Pharmaceuticals (NASDAQ:FENC) up US$43m despite increasing losses YoY, taking five-year CAGR to 16%
Simply Wall Street
Fennec Pharmaceuticals wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and...
2 months ago
Fennec Pharmaceuticals Strikes Major European Deal - TipRanks.com
Tipranks
Fennec Pharmaceuticals (TSE:FRX) has released an update. Fennec Pharmaceuticals has entered into an exclusive agreement with Norgine to commercialize...
2 months ago
Fennec signs commercialization deal for Pedmarqsi with Norgine
The Pharma Letter
Fennec signs commercialization deal for Pedmarqsi with Norgine ... US speciality drugmaker Fennec Pharmaceuticals (Nasdaq: FENC) and Norgine today...
2 months ago
Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Yahoo Finance
Consensus from 5 of the American Biotechs analysts is that Fennec Pharmaceuticals is on the verge of breakeven. They expect the company to post...
2 months ago
Fennec Pharmaceuticals Stock Expands Possible TAM Significantly (NASDAQ:FENC)
Seeking Alpha
Fennec Pharmaceuticals faced challenges and delays in obtaining FDA approval but finally launched PEDMARK® in late 2022.
6 months ago